Bradykinin specificity and signaling at GPR100 and B2 kinin receptors.
作者信息
Leeb-Lundberg L M Fredrik
机构信息
Department of Physiological Sciences, Lund University, SE-22184 Lund, Sweden.
出版信息
Br J Pharmacol. 2004 Dec;143(8):931-2. doi: 10.1038/sj.bjp.0706031. Epub 2004 Nov 15.
Abstract
摘要
相似文献
1
Bradykinin specificity and signaling at GPR100 and B2 kinin receptors.缓激肽在GPR100和B2激肽受体上的特异性及信号传导
Br J Pharmacol. 2004 Dec;143(8):931-2. doi: 10.1038/sj.bjp.0706031. Epub 2004 Nov 15.
2
Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology.缓激肽B2受体和GPR100受体：受体信号转导药理学的一个范例
Br J Pharmacol. 2004 Dec;143(8):938-41. doi: 10.1038/sj.bjp.0706025. Epub 2004 Nov 15.
3
[Bradykinin--with special reference to its action on nociceptors].[缓激肽——特别提及它对伤害感受器的作用]
Nihon Rinsho. 2005 Jan;63 Suppl 1:140-4.
4
Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling.缓激肽B2受体和线粒体ATP敏感性钾通道的间歇性激活通过氧化还原信号传导触发心脏后适应。
Cardiovasc Res. 2007 Jul 1;75(1):168-77. doi: 10.1016/j.cardiores.2007.03.001. Epub 2007 Mar 12.
5
Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.缓激肽的释放及脑内激肽B2受体的表达：在小鼠局灶性脑缺血后细胞死亡和脑水肿形成中的作用
J Cereb Blood Flow Metab. 2005 Aug;25(8):978-89. doi: 10.1038/sj.jcbfm.9600096.
6
C-terminal fusion of eGFP to the bradykinin B2 receptor strongly affects down-regulation but not receptor internalization or signaling.将增强型绿色荧光蛋白（eGFP）与缓激肽B2受体的C末端融合，强烈影响下调，但不影响受体内化或信号传导。
Biol Chem. 2006 May;387(5):603-10. doi: 10.1515/BC.2006.077.
7
The structure of the neuropeptide bradykinin bound to the human G-protein coupled receptor bradykinin B2 as determined by solid-state NMR spectroscopy.通过固态核磁共振光谱法测定的与人类G蛋白偶联受体缓激肽B2结合的神经肽缓激肽的结构。
Angew Chem Int Ed Engl. 2008;47(9):1668-71. doi: 10.1002/anie.200704282.
8
Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.内源性核缓激肽B2受体在即刻早期基因激活中介导信号传导的表达。
J Cell Physiol. 2008 Jul;216(1):234-44. doi: 10.1002/jcp.21398.
9
Activation of ERK, JNK, Akt, and G-protein coupled signaling by hybrid angiotensin II AT1/bradykinin B2 receptors expressed in HEK-293 cells.在HEK-293细胞中表达的血管紧张素II 1型受体/缓激肽2型受体杂合体对ERK、JNK、Akt和G蛋白偶联信号的激活作用。
J Cell Biochem. 2007 May 1;101(1):192-204. doi: 10.1002/jcb.21161.
10
International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.国际药理学联合会。XLV。激肽受体家族的分类：从分子机制到病理生理后果。
Pharmacol Rev. 2005 Mar;57(1):27-77. doi: 10.1124/pr.57.1.2.
引用本文的文献
1
Diabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change.糖尿病：通往失忆、人格与行为改变之路。
Biology (Basel). 2022 Feb 28;11(3):382. doi: 10.3390/biology11030382.
2
Subcellular hot spots of GPCR signaling promote vascular inflammation.G蛋白偶联受体（GPCR）信号传导的亚细胞热点促进血管炎症。
Curr Opin Endocr Metab Res. 2021 Feb;16:37-42. doi: 10.1016/j.coemr.2020.07.011. Epub 2020 Aug 18.
3
Hypothesized and found mechanisms for potentiation of bradykinin actions.缓激肽作用增强的假设机制与发现机制。
Signal Transduct. 2006 Feb;6(1):5-18. doi: 10.1002/sita.200500061. Epub 2006 Jan 17.
4
Bradykinin potentially stimulates cell proliferation in rabbit corneal endothelial cells through the ZO‑1/ZONAB pathway.缓激肽可能通过 ZO-1/ZONAB 通路刺激兔角膜内皮细胞的增殖。
Int J Mol Med. 2018 Jul;42(1):71-80. doi: 10.3892/ijmm.2018.3580. Epub 2018 Mar 22.
5
Involvement of bradykinin in brain edema development after ischemic stroke.缓激肽在缺血性中风后脑水肿形成中的作用。
Pflugers Arch. 2015 Feb;467(2):201-12. doi: 10.1007/s00424-014-1519-x. Epub 2014 Apr 23.
6
Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus.2型糖尿病认知和精神并发症中的血管病理学与血脑屏障破坏
Cardiovasc Psychiatry Neurol. 2011;2011:609202. doi: 10.1155/2011/609202. Epub 2011 Feb 17.
7
Cytosolic phospholipase A2alpha activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells.S1P诱导的胞质磷脂酶A2α激活由肺上皮细胞中的S1P3受体介导。
Am J Physiol Lung Cell Mol Physiol. 2008 Aug;295(2):L326-35. doi: 10.1152/ajplung.00393.2007. Epub 2008 May 23.
本文引用的文献
1
Identification and characterisation of GPR100 as a novel human G-protein-coupled bradykinin receptor.鉴定和表征GPR100作为一种新型人类G蛋白偶联缓激肽受体。
Br J Pharmacol. 2003 Nov;140(5):932-8. doi: 10.1038/sj.bjp.0705521. Epub 2003 Oct 6.
2
Identification of relaxin-3/INSL7 as a ligand for GPCR142.鉴定松弛素-3/胰岛素样肽7为G蛋白偶联受体142的配体。
J Biol Chem. 2003 Dec 12;278(50):50765-70. doi: 10.1074/jbc.M308996200. Epub 2003 Sep 30.
3
A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.缓激肽和合成激动剂FR190997与人类B2受体的不同分子相互作用：来自突变分析的证据。
Br J Pharmacol. 2003 Oct;140(3):500-6. doi: 10.1038/sj.bjp.0705454. Epub 2003 Aug 26.
4
Kinin receptors in pain and inflammation.疼痛与炎症中的激肽受体
Eur J Pharmacol. 2001 Oct 19;429(1-3):161-76. doi: 10.1016/s0014-2999(01)01318-8.
5
Inverse, protean, and ligand-selective agonism: matters of receptor conformation.反向、多变及配体选择性激动作用：受体构象问题
FASEB J. 2001 Mar;15(3):598-611. doi: 10.1096/fj.00-0438rev.
6
The B1 receptors for kinins.激肽的B1受体。
Pharmacol Rev. 1998 Sep;50(3):357-86.
7
Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons.
J Biol Chem. 1995 Jun 9;270(23):13706-10. doi: 10.1074/jbc.270.23.13706.
Zotero 插件